Så er vi på Ofatumumab studie 58
http://clinicaltrials.gov/ct2/show/NCT01361711?term=ofatumumab&rank=31
This phase II trial studies the side effects and how well giving alemtuzumab and ofatumumab together works in treating patients with previously untreated chronic lymphocytic leukemia (CLL).

]]>https://dev.proinvestor.com/forum/topic/448347/s-er-vi-p-ofatumumab-studie-58RSS for NodeSat, 20 Jun 2026 08:49:30 GMTTue, 31 May 2011 07:55:18 GMT60